Aug 18, 2025
1:15
For every 15 shares held, investors received 1. The price per share adjusted from $0.45 to $0.03.
The split itself did not change the total investment value.
Salarius Pharmaceuticals, Inc. (SLRX) trades on the NASDAQ Capital Market in the Biotechnology industry.
Salarius Pharmaceuticals, Inc. company overviewThe latest split shown was on August 18, 2025. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.
This history records 4 reverse splits between July 22, 2019 and August 18, 2025.